Logo image of TLPH

TALPHERA INC (TLPH) Stock Fundamental Analysis

USA - NASDAQ:TLPH - US00444T2096 - Common Stock

1.14 USD
-0.04 (-3.39%)
Last: 10/23/2025, 7:09:17 PM
1.14 USD
0 (0%)
After Hours: 10/23/2025, 7:09:17 PM
Fundamental Rating

2

Taking everything into account, TLPH scores 2 out of 10 in our fundamental rating. TLPH was compared to 191 industry peers in the Pharmaceuticals industry. TLPH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TLPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TLPH had negative earnings in the past year.
In the past year TLPH has reported a negative cash flow from operations.
In the past 5 years TLPH reported 4 times negative net income.
TLPH had a negative operating cash flow in each of the past 5 years.
TLPH Yearly Net Income VS EBIT VS OCF VS FCFTLPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

TLPH has a Return On Assets of -68.45%. This is in the lower half of the industry: TLPH underperforms 66.49% of its industry peers.
Looking at the Return On Equity, with a value of -170.59%, TLPH is doing worse than 69.11% of the companies in the same industry.
Industry RankSector Rank
ROA -68.45%
ROE -170.59%
ROIC N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLPH Yearly ROA, ROE, ROICTLPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TLPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLPH Yearly Profit, Operating, Gross MarginsTLPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K -2K

More info and screens

6

2. Health

2.1 Basic Checks

TLPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLPH has been increased compared to 1 year ago.
TLPH has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TLPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TLPH Yearly Shares OutstandingTLPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
TLPH Yearly Total Debt VS Total AssetsTLPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

TLPH has an Altman-Z score of -38.31. This is a bad value and indicates that TLPH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -38.31, TLPH is doing worse than 88.48% of the companies in the same industry.
TLPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -38.31
ROIC/WACCN/A
WACC8.61%
TLPH Yearly LT Debt VS Equity VS FCFTLPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

TLPH has a Current Ratio of 2.93. This indicates that TLPH is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.93, TLPH perfoms like the industry average, outperforming 56.54% of the companies in the same industry.
A Quick Ratio of 2.93 indicates that TLPH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.93, TLPH is in line with its industry, outperforming 58.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.93
TLPH Yearly Current Assets VS Current LiabilitesTLPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Revenue for TLPH has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

TLPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.69% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y-4.88%
EPS Next 3Y6.27%
EPS Next 5Y22.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLPH Yearly Revenue VS EstimatesTLPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
TLPH Yearly EPS VS EstimatesTLPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 5 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLPH. In the last year negative earnings were reported.
Also next year TLPH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLPH Price Earnings VS Forward Price EarningsTLPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLPH Per share dataTLPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.88%
EPS Next 3Y6.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLPH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALPHERA INC

NASDAQ:TLPH (10/23/2025, 7:09:17 PM)

After market: 1.14 0 (0%)

1.14

-0.04 (-3.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-04 2025-11-04
Inst Owners20.74%
Inst Owner ChangeN/A
Ins Owners9.03%
Ins Owner Change0.02%
Market Cap51.97M
Revenue(TTM)27.00K
Net Income(TTM)-11305000
Analysts82.22
Price Target4.25 (272.81%)
Short Float %2.45%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.3%
Min EPS beat(2)1.96%
Max EPS beat(2)34.64%
EPS beat(4)4
Avg EPS beat(4)32.88%
Min EPS beat(4)1.96%
Max EPS beat(4)57.11%
EPS beat(8)7
Avg EPS beat(8)30.58%
EPS beat(12)10
Avg EPS beat(12)20.73%
EPS beat(16)14
Avg EPS beat(16)18.14%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40%
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1924.91
P/FCF N/A
P/OCF N/A
P/B 7.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS0.15
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -68.45%
ROE -170.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 2.93
Altman-Z -38.31
F-Score2
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y0%
EPS Next 2Y-4.88%
EPS Next 3Y6.27%
EPS Next 5Y22.69%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.32%
OCF growth 3YN/A
OCF growth 5YN/A